MEMORIAL SLOAN KETTERING CANCER CENTER launched a molecular oncology and genomic analysis center, following a gift of $100 million.
THE ASSOCIATION OF COMMUNITY CANCER CENTERS selected five member institutions to serve as Community Resource Centers in the association's Improving Quality Care in Pancreatic Cancer project.
A bipartisan resolution designating May as the NATIONAL CANCER RESEARCH MONTH passed the Senate May 21. The resolution was sponsored by Sens. Dianne Feinstein (D-CA) and Johnny Isakson (R-GA).
As funding issues surrounding the NCI's new National Clinical Trials Network (NCTN) have been a prominent topic of recent news and discussions, to help inform the cancer research community, we are taking this opportunity to share data regarding NCTN funding to the Children's Oncology Group (COG).
In Their Own WordsThese comments by MD Anderson faculty and staff members were selected from an 835-page document. They appear exactly as they were keyed in, with no editing. The document was obtained under the Texas Public Information Act. Names and titles of MD Anderson officials were redacted.
“Much to Be Proud Of”In an email to employees, titled, “A BIG thank you,” DePinho lauded the high response rate, saying that the survey scores were favorable.
In a long-awaited survey of employees at MD Anderson Cancer Center, faculty members show a significant drop in approval scores for the administration's executive leadership, in comparison with the last time the survey was administered in 2012.
THE ONCOLOGY NURSING SOCIETY announced its 2014-2015 board of directors at its 39th Annual Congress.
THE CHILDREN'S ONCOLOGY DRUG ALLIANCE is joining the research and resources of the University of New South Wales and its commercialization arm, NewSouth Innovations; The Kids' Cancer Project, an Australia-based childhood cancer research charity; Novogen, an Australian oncology drug development company; and Nationwide Children's Hospital in Columbus, Ohio, to help accelerate development of a therapeutic approach to neuroblastoma.
MOFFITT CANCER CENTER began a collaboration with Vermillion Inc. to produce clinical and economic data to support a new value-based practice model that may improve survival, quality of life and cost-effectiveness of care for patients with ovarian cancer.
